Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times ... Step 4: Preparing a Trial Balance After all transactions are logged ...

Good afternoon, everyone and thank you for joining our conference call to discuss BioStem Technologies' first quarter 2025 financial results and corporate highlights. Leading the call today will be ...

The trial is examining the safety ... This information is based on a press release statement from Phio Pharmaceuticals. For deeper insights into Phio’s financial health and 12 additional ...

RGX-202 in Duchenne muscular dystrophy on track for BLA submission mid-2026 Pivotal trial more than half enrolled, with completion expected in 2025 Additional ...

Operator: Good day, ladies and gentlemen. Welcome to Assertio Holdings First Quarter 2025 Results Conference Call. Just a ...

Q1 2025 Earnings Call Transcript May 8, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.42 EPS, ...

While Gov. Greg Abbott steps up his push for stricter bail rules, critics seek a balance between the rights of the accused ...

Q1 2025 Earnings Call Transcript May 8, 2025 Operator: Good morning, everyone and welcome to D-Wave’s First Quarter Fiscal ...

Axogen, Inc. ( NASDAQ: AXGN) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Michael Dale - Chairman & Chief Executive Officer Nir Naor - Chief Financial Officer Jens Kemp - Chief Marketing ...

According to InvestingPro data, the company’s stock has seen significant volatility, declining over 80% in the past year despite maintaining a strong balance sheet with more cash than debt. In the ...

The trial is examining the safety and efficacy ... This information is based on a press release statement from Phio Pharmaceuticals. For deeper insights into Phio’s financial health and 12 additional ...